Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned an average recommendation of “Buy” from the twenty-two ratings firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $529.34.
A number of analysts recently issued reports on ISRG shares. Goldman Sachs Group increased their target price on shares of Intuitive Surgical from $540.00 to $630.00 and gave the stock a “buy” rating in a research report on Friday, July 20th. Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $515.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, July 20th. Cantor Fitzgerald reissued a “buy” rating and set a $620.00 target price (up previously from $510.00) on shares of Intuitive Surgical in a research report on Friday, July 20th. Bank of America increased their target price on shares of Intuitive Surgical from $510.00 to $600.00 and gave the stock a “buy” rating in a research report on Tuesday, July 17th. Finally, Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $582.00 price objective for the company in a research report on Tuesday, July 24th.
In other Intuitive Surgical news, Director Lonnie M. Smith sold 56,000 shares of the stock in a transaction that occurred on Tuesday, July 24th. The shares were sold at an average price of $523.37, for a total value of $29,308,720.00. Following the completion of the sale, the director now owns 11,874 shares of the company’s stock, valued at $6,214,495.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Mark J. Rubash sold 150 shares of the firm’s stock in a transaction that occurred on Monday, August 27th. The stock was sold at an average price of $543.66, for a total transaction of $81,549.00. Following the sale, the director now directly owns 4,116 shares of the company’s stock, valued at approximately $2,237,704.56. The disclosure for this sale can be found here. Insiders sold 109,463 shares of company stock valued at $57,194,982 in the last ninety days. 2.20% of the stock is owned by corporate insiders.
ISRG traded up $9.54 on Friday, reaching $568.36. 840,350 shares of the company’s stock were exchanged, compared to its average volume of 456,689. The company has a market cap of $62.51 billion, a PE ratio of 79.05, a price-to-earnings-growth ratio of 4.02 and a beta of 0.86. Intuitive Surgical has a twelve month low of $337.80 and a twelve month high of $572.96.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 19th. The medical equipment provider reported $2.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.02 by $0.74. The firm had revenue of $909.30 million during the quarter, compared to the consensus estimate of $877.43 million. Intuitive Surgical had a net margin of 23.20% and a return on equity of 20.56%. The company’s revenue was up 19.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.95 EPS. analysts expect that Intuitive Surgical will post 9.31 EPS for the current year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Featured Story: What are CEFs?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.